Remove oncology webinars
article thumbnail

Immuno-oncology market set to grow in billions, but access concerns remain

Pharmaceutical Technology

The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in multiple indications in the past decade. Checkpoint modulators are forecasted to retain the largest share of this, based on the webinar. This high compound annual growth rate of 23.6%

Marketing 105
article thumbnail

Meeting MSL training needs in an evolving landscape

pharmaphorum

Healthcare professionals trust MSLs to keep them informed and up-to-date about the latest treatments, especially in fast-moving areas like oncology. This webinar will also explore: How the changing nature of communications technology and modalities are changing the MSL’s role.

Training 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Fireside Chat with Dr. Luca Dezzani, VP, US Oncology Medical Affairs at Johnson & Johnson

Impetus Digital

Register for Impetus’ upcoming live webinar on September 28, 2 – 3 PM ET: A Fireside Chat with Fireside Chat with Dr. Luca Dezzani, VP, US Oncology Medical Affairs at Johnson & Johnson. About the webinar. Register for this free webinar. Sign up now so that you don’t miss out! Click here to register.

Medical 52
article thumbnail

[WEBINAR] Video, Voice, and Virtual: Applying New Digital Technology to Enhance Customer Experience

Pharma Marketing Network

As telehealth appointments replaced office visits, webinars replaced in-person conferences and digital communication replaced reps in the field, what have we learned about how to create connection within this new paradigm? Ryan Billings , Head, US Oncology Digital Marketing & Customer Experience at GSK. SAVE MY SEAT.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

In this exclusive webinar, Dr. Ben Locwin will discuss the potential effects of this draft, along with the pharmacological and toxicological considerations for optimizing doses of prescription drugs. What will the future hold for clinical research? A recent draft from the FDA provides valuable insight.

article thumbnail

Cost & Management of Oncology Combination Regimens

pharmaphorum

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. Traditional utilization management tools are still difficult to apply in oncology, given no payer wants to be on the front page of a major newspaper for denying treatment. Pathways have not held up to their promise for containing cost.

article thumbnail

Social medical: The social media buzz around ASCO 2016

pharmaphorum

The ASCO Annual Meeting, the largest global oncology meeting and increasingly the centre of a kaleidoscope of social media coverage each year. This webinar will examine the conversation around ASCO 2016, its relationship with ASCO, value to and involvement from stakeholder groups and how it will potentially continue to evolve into 2017.

Media 52